Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice.

about

Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice.

Item

http://www.wikidata.org/entity/Q35845580

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Focused molecular analysis of ...... in routine clinical practice.

@ast

Focused molecular analysis of ...... in routine clinical practice.

@en

type

Item

label

Focused molecular analysis of ...... in routine clinical practice.

@ast

Focused molecular analysis of ...... in routine clinical practice.

@en

prefLabel

Focused molecular analysis of ...... in routine clinical practice.

@ast

Focused molecular analysis of ...... in routine clinical practice.

@en

P1476

Focused molecular analysis of ...... in routine clinical practice.

@en

P2093

Andrew Wotherspoon

http://www.w3.org/2001/XMLSchema#string

Ayatallah Nassef

http://www.w3.org/2001/XMLSchema#string

David Gonzalez de Castro

http://www.w3.org/2001/XMLSchema#string

Debbie Mair

http://www.w3.org/2001/XMLSchema#string

Fatma Abdelraouf

http://www.w3.org/2001/XMLSchema#string

Jaishree Bhosle

http://www.w3.org/2001/XMLSchema#string

Manisha Maurya

http://www.w3.org/2001/XMLSchema#string

Mary O'Brien

http://www.w3.org/2001/XMLSchema#string

Taghrid Gaafar

http://www.w3.org/2001/XMLSchema#string

Timothy A Yap

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic profiling of small-cell lung cancer: the era of targeted therapies

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Treatment options for small cell lung cancer - do we have more choice?

Prophylactic cranial irradiation in extensive small-cell lung cancer.

Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer.

Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.

Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide

Targeted therapies in small cell lung cancer: a review

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

P2888

s13104-015-1675-x

P304

688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13104-015-1675-X

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sanjay Popat

Alexandra Leary

Adam Sharp

P577

2015-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284185717

http://www.w3.org/2001/XMLSchema#string

P6179

1027977275

http://www.w3.org/2001/XMLSchema#string

P698

26581482

http://www.w3.org/2001/XMLSchema#string

P932

4652351

http://www.w3.org/2001/XMLSchema#string